RESEARCH TRIANGLE PARK, N.C. , April 15, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its first quarter 2026 financial results on Wednesday, May 6, 2026.
Read more at globenewswire.comBioCryst to Report First Quarter 2026 Financial Results on May 6
Provided By GlobeNewswire – Last update: